We have established a fully integrated discovery platform that has successfully generated many novels and differentiated drug candidates. We continue to expeditiously advancing our programs in clinic and aim to accelerate time-to-market and successful commercialization. We are also making a broad range of efforts to maximize the therapeutic values of every program by expanding their indications and geographical coverage.